Evidence map›Paper›PMID 37510083›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Assessment of the Tumor-Stroma Ratio and Tumor-Infiltrating Lymphocytes in Colorectal Cancer: Inter-Observer Agreement Evaluation.

Azar Kazemi, Masoumeh Gharib, Nema Mohamadian Roshan, Shirin Taraz Jamshidi, Fabian Stögbauer, Saeid Eslami, Peter J Schüffler

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Azar KazemiInstitute of General and Surgical Pathology, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0003-3197-0491
Masoumeh GharibDepartment of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9137913316, Iran.ORCID 0000-0003-2501-2684
Nema Mohamadian RoshanDepartment of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9137913316, Iran.ORCID 0000-0002-7862-7140
Shirin Taraz JamshidiDepartment of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 9137913316, Iran.ORCID 0000-0002-5954-493X
Fabian StögbauerInstitute of General and Surgical Pathology, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-8897-5165
Saeid EslamiDepartment of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad 9177948564, Iran.ORCID 0000-0003-3755-1212
Peter J SchüfflerInstitute of General and Surgical Pathology, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-1353-8921

Funding

Mashhad University of Medical Sciences 990801
6 · The paper itself

Abstract

backgroundTo implement the new marker in clinical practice, reliability assessment, validation, and standardization of utilization must be applied. This study evaluated the reliability of tumor-infiltrating lymphocytes (TILs) and tumor-stroma ratio (TSR) assessment through conventional microscopy by comparing observers' estimations.

methodsIntratumoral and tumor-front stromal TILs, and TSR, were assessed by three pathologists using 86 CRC HE slides. TSR and TILs were categorized using one and four different proposed cutoff systems, respectively, and agreement was assessed using the intraclass coefficient (ICC) and Cohen's kappa statistics. Pairwise evaluation of agreement was performed using the Fleiss kappa statistic and the concordance rate and it was visualized by Bland-Altman plots. To investigate the association between biomarkers and patient data, Pearson's correlation analysis was applied.

resultsFor the evaluation of intratumoral stromal TILs, ICC of 0.505 (95% CI: 0.35-0.64) was obtained, kappa values were in the range of 0.21 to 0.38, and concordance rates in the range of 0.61 to 0.72. For the evaluation of tumor-front TILs, ICC was 0.52 (95% CI: 0.32-0.67), the overall kappa value ranged from 0.24 to 0.30, and the concordance rate ranged from 0.66 to 0.72. For estimating the TSR, the ICC was 0.48 (95% CI: 0.35-0.60), the kappa value was 0.49 and the concordance rate was 0.76. We observed a significant correlation between tumor grade and the median of TSR (0.29 (95% CI: 0.032-0.51),

conclusionsThe agreement between pathologists in estimating these markers corresponds to poor-to-moderate agreement; implementing immune scores in daily practice requires more concentration in inter-observer agreements.

Indexed as

colorectal cancerinter-observertumor-infiltrating lymphocytestumor–stroma ratio

Identifiers

PMID37510083
PMCPMC10378655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.